 |
인쇄하기
취소
|
TEVA-HANDOK received permission for bioequivalence test of 'Aricept' for the first time in Korea
(dailypharm)
TEVA-HANDOK received permission for bioequivalence test to develop generic version of Aricept for the first time in Korea. Starting with this product, generic introduction is expected to be greatly expanded. Ministry of Food and Drug Safety authorized bioequivalence test of TEVA-HANDOK 'donepezil hydrochloride monohydrate 10mg' on 20 December.
The original product of this co...
TEVA-HANDOK received permission for bioequivalence test to develop generic version of Aricept for the first time in Korea. Starting with this product, generic introduction is expected to be greatly expanded. Ministry of Food and Drug Safety authorized bioequivalence test of TEVA-HANDOK 'donepezil hydrochloride monohydrate 10mg' on 20 December.
The original product of this co...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.